Search Results 721-730 of 18268 for Immunode

  1. Ibrutinib and Ixazomib Citrate in Treating Participants With Relapsed or Refractory Waldenstrom Macroglobulinemia - Mayo Clinic

    Ongoing, active hepatitis B or C virus infection, or known human immunodeficiency virus (HIV) positive. Liver disease with Child-Pugh class B or C liver ...

  2. A Study to Test the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer - Mayo Clinic

    Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months of Step 2 ...

  3. Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery - Mayo Clinic

    Known history of human immunodeficiency virus (HIV) infection, hepatitis B, or hepatitis C; testing is not required in the absence of clinical findings or ...

  4. A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus - Mayo Clinic

    * History of congenital or acquired immunodeficiency. * Known active infection, or any major episode of infection requiring hospitalization or treatment ...

  5. Transplant Medicine Clinical Trials - Medical Professionals

    Find transplant clinical trials at your nearest Mayo Clinic location.

  6. A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease - Mayo Clinic

    ... immunodeficiency. Local manifestations of Crohn's Disease (CD) such as abscesses, short bowel syndrome; or other disease complications for which surgery ...

  7. Consumer health - Mayo Clinic

    Take charge of your health. Know your options. Use medicines and supplements wisely. Be informed and ask questions of your health care professionals.

  8. Combination of Serabelisib and Insulin Suppressing Diet in Subjects With Advanced Solid Tumors with PIK3CA Mutations - Mayo Clinic

    Subjects with poorly controlled human immunodeficiency virus, hepatitis B virus, and/or hepatitis C virus infections. 23. Known allergies to nab-paclitaxel ...

  9. Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab Intravenous (Dara-IV) - Mayo Clinic

    ... immunodeficiency syndrome (AIDS)-defining opportunistic infection within 6 months of start of screening, and not agreeing to start ART and be on ART > 4 ...

  10. https://www.mayoclinic.org/chinese_patient_consumer_video.xml